Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongyi Zeng

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Nature Communications|August 28, 2025
Granzyme B activated near-infrared-II ratiometric fluorescent nanoprobe for early detection of tumor response to immunotherapyLei Ding, Xiaolong Zhang, Peiyuan Wang, et al.
Cancer Letters|November 10, 2025
Multimodal deep learning model for predicting prognosis following radiotherapy-based combination therapy in unresectable hepatocellular carcinomaHaoming Xia, Qizhen Huang, Ziyue Huang, et al.
Cancer Medicine|February 20, 2020
Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective studyLei Wang, Manjun Deng, Qiao Ke, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 22, 2021
Cytosolic Delivery of Thiolated Neoantigen Nano-Vaccine Combined with Immune Checkpoint Blockade to Boost Anti-Cancer T Cell ImmunityDa Zhang, Ziguo Lin, Ming Wu, et al.
Frontiers in Oncology|March 29, 2021
Prognostic Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Patients With Clinically Negative Lymph Node Metastasis: A Multi-Center Study From ChinaQiao Ke, Lei Wang, Ziguo Lin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 6, 2025
Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort studyDongxu Yin, Zixuan Wang, Chao Li, et al.
Hepatology International|March 27, 2025
Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter studyQizhen Huang, Xiaohong Zhong, Shaoxing Chen, et al.
BMC Cancer|September 11, 2023
Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysisQiao Ke, Lei Wang, Ziguo Lin, et al.
Scandinavian Journal of Gastroenterology|August 29, 2022
Dynamic evaluation of postoperative survival in intrahepatic cholangiocarcinoma patients who did not undergo lymphadenectomy: a multicenter studyTingfeng Huang, Jie Kong, Hongzhi Liu, et al.
Annals of Surgical Oncology|October 26, 2025
Long-Term Survival and Beneficiaries of Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular CarcinomaBin Guo, Chu Luo, Yuanxiang Lu, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Nature Communications|August 28, 2025
Granzyme B activated near-infrared-II ratiometric fluorescent nanoprobe for early detection of tumor response to immunotherapyLei Ding, Xiaolong Zhang, Peiyuan Wang, et al.
Cancer Letters|November 10, 2025
Multimodal deep learning model for predicting prognosis following radiotherapy-based combination therapy in unresectable hepatocellular carcinomaHaoming Xia, Qizhen Huang, Ziyue Huang, et al.
Cancer Medicine|February 20, 2020
Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective studyLei Wang, Manjun Deng, Qiao Ke, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 22, 2021
Cytosolic Delivery of Thiolated Neoantigen Nano-Vaccine Combined with Immune Checkpoint Blockade to Boost Anti-Cancer T Cell ImmunityDa Zhang, Ziguo Lin, Ming Wu, et al.
Frontiers in Oncology|March 29, 2021
Prognostic Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Patients With Clinically Negative Lymph Node Metastasis: A Multi-Center Study From ChinaQiao Ke, Lei Wang, Ziguo Lin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 6, 2025
Preoperative ASAP score predicts recurrence and survival following curative hepatic resection for hepatitis B virus-related hepatocellular carcinoma: A multicenter cohort studyDongxu Yin, Zixuan Wang, Chao Li, et al.
Hepatology International|March 27, 2025
Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter studyQizhen Huang, Xiaohong Zhong, Shaoxing Chen, et al.
BMC Cancer|September 11, 2023
Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysisQiao Ke, Lei Wang, Ziguo Lin, et al.
Scandinavian Journal of Gastroenterology|August 29, 2022
Dynamic evaluation of postoperative survival in intrahepatic cholangiocarcinoma patients who did not undergo lymphadenectomy: a multicenter studyTingfeng Huang, Jie Kong, Hongzhi Liu, et al.
Annals of Surgical Oncology|October 26, 2025
Long-Term Survival and Beneficiaries of Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular CarcinomaBin Guo, Chu Luo, Yuanxiang Lu, et al.
Pageof 20